Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (08/09/2010)
A systematic review of 47 studies evaluating treatment for melanoma, head and neck cancer, genitourinary cancers, gynecologic cancers, and sarcoma indicates that lymphedema is a common side effect of treatment for these diseases.

Laparoscopic Hysterectomy for Endometrial Cancer Associated with Better Quality of Life (08/03/2010)
Laparoscopic hysterectomy for endometrial cancer that is confined to the uterus is associated with less pain, shorter hospital stays, faster recovery, and better quality of life when compared with total abdominal hysterectomy, according to the results of two studies published in The Lancet Oncology.

High Circulating Vitamin D Levels Don’t Reduce Risk of Less Common Cancers (07/12/2010)
High levels of vitamin D in the bloodstream do not appear to reduce the risk of seven less common cancers: endometrial, esophageal, stomach, ovarian, pancreatic, kidney, and non-Hodgkin’s lymphoma.

Two Behaviors May Affect Risk of Endometrial Cancer (05/21/2010)
Two recent studies have identified behaviors that may affect risk of endometrial cancer: physical activity, which may reduce risk, and perineal use of talcum powder, which may increase risk. Results from both of these studies were published in Cancer Epidemiology, Biomarkers & Prevention.

Vaginal Brachytherapy Effective for Endometrial Cancer (03/17/2010)
Among women who have undergone surgery for high-intermediate risk endometrial cancer, vaginal brachytherapy is as effective as pelvic external beam radiotherapy in the prevention of vaginal recurrence and produces fewer side effects. These results were published in Lancet.

▪ More...

High Circulating Vitamin D Levels Don’t Reduce Risk of Less Common Cancers (07/12/2010)
High levels of vitamin D in the bloodstream do not appear to reduce the risk of seven less common cancers: endometrial, esophageal, stomach, ovarian, pancreatic, kidney, and non-Hodgkin’s lymphoma.

Two Behaviors May Affect Risk of Endometrial Cancer (05/21/2010)
Two recent studies have identified behaviors that may affect risk of endometrial cancer: physical activity, which may reduce risk, and perineal use of talcum powder, which may increase risk. Results from both of these studies were published in Cancer Epidemiology, Biomarkers & Prevention.

Regular Aspirin Use May Reduce Risk of Ovarian Cancer (02/17/2010)
According to results from the Iowa Women’s Health Study, regular aspirin use may reduce the risk of developing ovarian cancer but does not appear to affect the risk of endometrial cancer. These results were published in Cancer Epidemiology, Biomarkers, and Prevention.

Coffee Consumption May Reduce Risk of Uterine Cancer (10/20/2009)
Coffee consumption may reduce the incidence of uterine cancer, especially among overweight and obese women, according to the results of a study published in the International Journal of Cancer.

Being Overweight Associated with Increased Risk of Several Cancers (02/19/2008)
Excess bodyweight increases the risk of developing several types of cancer, according to results recently published in The Lancet.

▪ More...

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (08/09/2010)
A systematic review of 47 studies evaluating treatment for melanoma, head and neck cancer, genitourinary cancers, gynecologic cancers, and sarcoma indicates that lymphedema is a common side effect of treatment for these diseases.

Laparoscopic Hysterectomy for Endometrial Cancer Associated with Better Quality of Life (08/03/2010)
Laparoscopic hysterectomy for endometrial cancer that is confined to the uterus is associated with less pain, shorter hospital stays, faster recovery, and better quality of life when compared with total abdominal hysterectomy, according to the results of two studies published in The Lancet Oncology.

Vaginal Brachytherapy Effective for Endometrial Cancer (03/17/2010)
Among women who have undergone surgery for high-intermediate risk endometrial cancer, vaginal brachytherapy is as effective as pelvic external beam radiotherapy in the prevention of vaginal recurrence and produces fewer side effects. These results were published in Lancet.

Adjuvant Radiation Therapy May Improve Survival in Stage III Uterine Cancer (10/22/2009)
Among women with node-positive Stage III uterine cancer, use of adjuvant (post-surgery) radiation therapy appears to improve survival. These results were published in Gynecologic Oncology.

Removal of Ovaries May Not Be Necessary in Young Women with Endometrial Cancer (01/29/2009)
According to the results of a study published in the Journal of Clinical Oncology, removal of the ovaries may not be necessary in young women treated with hysterectomy for early-stage endometrial (uterine) cancer.

▪ More...

Updates in the Management of Gynecologic Cancers (05/27/2008)
A Report from the 39^th Annual Meeting of the Society of Gynecologic Oncologists

Risk Factors Identified for Uterine Sarcoma Survival (02/20/2008)
Survival for patients diagnosed with uterine leiomyosarcomas may be influenced by several factors. These findings were recently published in the journal Cancer.

Psychosocial Needs of Survivors of Gynecologic Cancers Must Be Addressed (01/29/2007)
According to an article recently published in Gynecologic Oncology, nearly one-third of survivors of a gynecologic cancer suffer from anxiety or post-traumatic stress disorder symptoms.

More Extensive Lymph Node Removal Improves Survival in Intermediate- and High-risk Endometrial Cancer Patients (09/25/2006)
According to the results of a study published in the journal Cancer, removal of a larger number of lymph nodes improves survival among women with intermediate or high-risk endometrial cancer (Stage IB, Grade 3; Stage IC-IV, all grades).

Chemotherapy Superior to Radiation in the treatment of Carcinosarcoma of the Uterus (06/06/2006)
Chemotherapy has been shown to improve survival compared to whole abdominal radiation in the treatment of women with a rare form of uterine cancer—carcinosarcoma of the uterus—who have undergone surgery to remove most of their disease. These results were presented at the 42nd annual meeting of the American Society of Clinical Oncology (ASCO) held in Atlanta, Georgia, June 2-6, 2006.

▪ More...

Combination of Hycamtin® and Taxotere® Shows Promise in Treatment of Recurrent Gynecologic Cancers (05/12/2009)
Among women with recurrent ovarian or endometrial (uterine) cancer, 25% experienced a partial or complete response to treatment with Hycamtin® (topotecan) and Taxotere® (docetaxel). The results of this Phase II clinical trial will be published in Gynecologic Oncology.

Neulasta® on First Day of Chemotherapy May Be More Convenient for Gynecologic Cancers (03/17/2008)
The administration of the blood cell growth factor Neulasta® (pegfilgrastim) on the first day of chemotherapy among women with gynecologic cancers may be as effective as and more convenient than second-day administration. These results were recently reported at the 2008 annual Society of Gynecologic Oncologists meeting.

Stress and Depression Frequent Among Women Treated for Gynecological Cancers (02/22/2005)
According to the results of a study recently published in Gynecologic Oncology, women with gynecologic cancer often experience emotional stress and depression after losing their fertility from cancer treatment.

Oral Etoposide Shows Modest Activity, with Minimal Side Effects, against Recurrent Endometrial Cancer (02/26/2002)
Chemotherapy with oral etoposide may benefit women who have recurrent or metastatic endometrial cancer, and may hold promise for improved effectiveness when used in combination with other drugs, according to a recent report by the Southwest Oncology Group.

Brachytherapy after Surgery Appears to Help Prevent Recurrences in Persons with Stage I Endometrial Cancer (02/26/2002)
The use of brachytherapy (radioactive implants) after surgery for stage I endometrial cancer appears to help prevent cancer recurrences in the area of the uterus, according to a new study by Arizona researchers. This finding offers hope for an effective alternative to external-beam radiation therapy for women with this disease.

▪ More...